High incidence of breakthrough varicella observed in healthy Japanese children immunized with live attenuated varicella vaccine (Oka strain)

Pediatrics International

Volumn 39, Issue 6, 1997, Pages 663-668

  Takayama, Naohide ^a   Minamitani, Mikio ^a   Takayama, Michiko ^b  

^a TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Breakthrough varicella; Incidence; Varicella vaccine

Indexed keywords

CHICKENPOX VACCINE;

ADOLESCENT; ARTICLE; CHICKENPOX; CHILD; FOLLOW UP; HEALTH SURVEY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INCIDENCE; INFANT; INFECTION RATE; INFECTION RISK; NORMAL HUMAN; PRIORITY JOURNAL; REINFORCEMENT; SEROCONVERSION; VACCINATION;

ADOLESCENT; ANTIBODIES, VIRAL; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION; INFANT; JAPAN; VACCINES, ATTENUATED;

EID: 0031472880     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1997.tb03664.x     Document Type: Article

References (20)

1. Takahashi M. Gershon AA. Varicella Vaccine. In: Plotkin SA, Mortimer EA (eds). Vaccines. WB Saunders, Philadelphia, 1994;387–418.
2. Asano Y., Suga S., Yoshikawa T. et al. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 1994; 94: 524–6.
3. Arbeter AM, Starr, SE, Preblud SR et al. Varicella vaccine trials in healthy children. Am. J. Dis. Child. 1984; 138: 434–8.
4. Johnson CE, Shurin PA, Fattlar D., Rome LP, Kumar ML. Live attenuated varicella vaccine in healthy 12- to 24-month-old children. Pediatrics 1988; 81: 512–18.
5. Weibel RE, Neff BJ, Kuter BJ et al. Live attenuated varicella virus vaccine: Efficacy trial in healthy children. N. Engl. J. Med. 1984: 310: 1409–15.
6. Watson BM, Piercy SA, Plotikin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993; 91: 17–22.
7. White CJ, Kuter BJ, Ngai A. et al. Modified cases of chicken-pox after varicella vaccination: correlation of protection with antibody response. Pediatr. Infect. Dis. J. 1992; 11: 19–23.
8. Asano Y., Nagai T., Miyama T. et al. Long-term protective immunity of recepients of the Oka strain of live varicella vaccine. Pediatrics 1985; 75: 667–71.
9. Krause PR, Klinman DM. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J. Pediatr. 1995; 127: 518–25.
10. White CJ, Kuter BJ, Hildebrand CS et al. Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trial, 1987–1989. Pediatrics 1991; 87: 604–10.
11. Kuter BJ, Weibel RE, Guess HA et al. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 1991; 9: 643–7.
12. Takayama N., Mitamitani M. Mild varicella observed in children vaccinated with varicella vaccine between 1984 and 1987. J. Jpn. Assoc. Infect. Dis. 1990; 64: 188–94. (in Jpn. with Engl. abstr.).
13. Ozaki T., Nagai T., Kimura T. et al. The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals. Biken J. 1980; 23: 9–14.
14. Bernstein HH, Rothstein EP, Watson BM et al. Clinical survey of natural varicella compared with breakthrough varicella after immunization with Live Attenuated Oka/Merk varicella vaccine. Pediatrics 1993; 92: 833–7.
15. Johnson C., Rome LP, Stancin T. Kumar ML. Humoral immunity and clinical reinfections following varicella vaccine in healthy children. Pediatrics 1989; 84: 418–21.
16. Arvin AM, Koropchak CM, Wittek AE. Immunologic evidence of reinfection with varicella-zoster virus. J. Infect. Dis. 1983; 148: 200–5.
17. Bogger-Goren S., Baba, K., Hurley P., Yabuuchi H., Takahashi M., Ogra PL. Antibody response to varicella-zoster virus after natural or vaccine-induced infection. J. Infect. Dis. 1982; 146: 260–5.
18. Gershon AA, Steinberg SP, Gelb L. et al. Clinical reinfection with varicella-zoster virus. J. Infect. Dis. 1984: 149: 137–42.
19. Junker AK, Angus FE, Thomas EE. Recurrent varicella-zoster virus infections in apparently immunocompetent children. Pediatr. Infect. Dis. J. 1991; 10: 569–75.
20. Martin KA, Junker AK, Thomas EE, Van Allen Ml, Friedman JM. Occurrence of chickenpox during pregnancy in women seropositive for varicella-zoster virus. J. Infect. Dis. 1994;170: 991–5.